Results
Sana Biotechnology EPS Miss, Shares Up 2.3%
Sana Biotechnology posted Q1 2026 loss of $0.17 per share, missing estimates, with no revenue and net loss of $47.2 million.
Shares rose 2.3% after-hours as the company announced a strategic Mayo Clin
